valganciclovir accord 450 mg
accord healthcare b.v. - valganciklovirhydroklorid - tablett, filmdrasjert - 450 mg
valganciclovir sandoz 450 mg
sandoz - københavn - valganciklovirhydroklorid - tablett, filmdrasjert - 450 mg
valganciclovir medical valley 450 mg
medical valley invest ab - valganciklovirhydroklorid - tablett, filmdrasjert - 450 mg
livtencity
takeda pharmaceuticals international ag ireland branch - maribavir - cytomegalovirusinfeksjoner - antivirale midler til systemisk bruk - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). det bør vurderes å offisielle retningslinjer for riktig bruk av antivirale midler.
valaciclovir sandoz 500 mg
sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 500 mg
valaciclovir sandoz 250 mg
sandoz a/s - valaciklovirhydroklorid - tablett, filmdrasjert - 250 mg
valtrex 250 mg
glaxosmithkline as - valaciklovirhydroklorid - tablett, filmdrasjert - 250 mg
valtrex 500 mg
glaxosmithkline as - valaciklovirhydroklorid - tablett, filmdrasjert - 500 mg
valcyte 450 mg
cheplapharm arzneimittel gmbh - valganciklovirhydroklorid - tablett, filmdrasjert - 450 mg
valcyte 50 mg/ ml
cheplapharm arzneimittel gmbh - valganciklovirhydroklorid - pulver til mikstur, oppløsning - 50 mg/ ml